mRNA-technologies: opportunities and outlooks

28 April 2025 — Tomsk, Russia

Registration is closed

About

Dear colleagues,

Advances in mRNA development have significantly expanded the possibilities for treating various diseases. mRNA-based technologies provide a convenient and highly effective method for delivering genetic information into cells and offer several significant advantages for clinical practice. mRNA-based drugs can activate the immune response against infectious and tumor antigens and restore gene functions in cases of mutations.

The scientific seminar "mRNA-technologies: opportunities and outlooks" will bring together specialists in molecular and cellular biology, bioinformatics, mRNA synthesis, and the development of delivery systems, as well as practicing physicians across various specialties.

We hope that the seminar will make a valuable contribution to advancing mRNA technologies and accelerating their translation into medical practice.

Participation is free of charge

Venue & Time

Date:28 April 2025
Participation format:On-line & off-line
Venue: 5 Kooperativny Street, Tomsk, Russia
Cancer Research Institute of Tomsk National Research Medical Center

Organizations

Chairpersons

Evgeny Choynzonov

Evgeny Choynzonov

Cancer Research Institute, Tomsk NRMC

Dmitry Pyshny

Dmitry Pyshny

Deputy Minister of Science and Higher Education of the Russian Federation

Vadim Stepanov

Vadim Stepanov

Cancer Research Institute, Tomsk NRMC

Alexander Agafonov

Alexander Agafonov

State Research Center of Virology and Biotechnology VECTOR

Vladimir Koval

Vladimir Koval

Ph.D., Director of Institute of Chemical Biology and Fundamental Medicine

Nadezhda Cherdyntseva

Nadezhda Cherdyntseva

Cancer Research Institute, Tomsk NRMC

Evgeny Denisov

Evgeny Denisov

Cancer Research Institute, Tomsk NRMC; RUDN University

Andrey Rudometov

Andrey Rudometov

State Research Center of Virology and Biotechnology VECTOR

Alexander Ilyichev

Alexander Ilyichev

State Research Center of Virology and Biotechnology VECTOR

Larisa Karpenko

Larisa Karpenko

State Research Center of Virology and Biotechnology VECTOR

Grigory Stepanov

Grigory Stepanov

Institute of Chemical Biology and Fundamental Medicine

Organising Committee

Marina Patysheva

Marina Patysheva

Cancer Research Institute, Tomsk NRMC

Anton Fedorov

Anton Fedorov

Cancer Research Institute, Tomsk NRMC

Arina Ibragimova

Arina Ibragimova

Cancer Research Institute, Tomsk NRMC

Ustinya Bokova

Ustinya Bokova

Cancer Research Institute, Tomsk NRMC

Elene Popova

Elene Popova

Tomsk State University

Sultanova Daria

Sultanova Daria

Siberian State Medical University

Partners

Program

Speakers

Evgeny Denisov

Evgeny Denisov

Cancer Research Institute, Tomsk NRMC; RUDN University

Larisa Karpenko

Larisa Karpenko

State Research Center of Virology and Biotechnology VECTOR

Alexander Ilyichev

Alexander Ilyichev

State Research Center of Virology and Biotechnology VECTOR

Dr. William S. C. Ngai

Dr. William S. C. Ngai

Plasmid Process Development, YXgene

Vasiliy Reshetnikov

Vasiliy Reshetnikov

Sirius University of Science and Technology

Mikhail Maslov

Mikhail Maslov

Lomonosov Institute of Fine Chemical Technologies, MIREA – Russian Technological University

Yulia Kotsur

Yulia Kotsur

St. Petersburg State Chemical and Pharmaceutical University

Andrey Rudometov

Andrey Rudometov

State Research Center of Virology and Biotechnology VECTOR

Nikolay Skryabin

Nikolay Skryabin

Research Institute of Medical Genetics, Tomsk NRMC

Marina Patysheva

Marina Patysheva

Cancer Research Institute, Tomsk NRMC

Oleg Markov

Oleg Markov

Institute of Chemical Biology and Fundamental Medicine

Sergei Sharabrin

Sergei Sharabrin

State Research Center of Virology and Biotechnology VECTOR

Egor Veselovskii

Egor Veselovskii

National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Dr. Xian Zeng

Dr. Xian Zeng

Byterna Therapeutics

Elena Chernolovskaya

Elena Chernolovskaya

Institute of Chemical Biology and Fundamental Medicine